[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

NCT07020806 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Lobular Breast Carcinoma

Interventions

DRUG: [68Ga]Ga DOTA-5G

Sponsor

University of California, Davis

Collaborators

[object Object]
[object Object]
[object Object]